The first-ever oral GLP-1 medication for weight loss has been approved for use in the U.S. The Wegovy pill, from drugmaker Novo Nordisk, was cleared by the Food and Drug Administration to reduce ...

BOSTON — Starting in January, public workers and retirees enrolled in Group Insurance Commission plans will need to participate in a new program to maintain coverage for GLP-1 prescriptions as the ...

(Reuters) -Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's new national priority voucher, suggesting it is a strong candidate ...

An Eli Lilly drug candidate designed to hit three metabolic targets led patients to lose an average of 28.7% of their body weight in a late-stage clinical trial, setting a new high mark in the ...

GLP-1 medications, such as Ozempic and Wegovy, have skyrocketed in popularity and are used to treat type 2 diabetes and aid in weight loss. However, studies show they do not work for everyone, ...

Lilly says weight-loss pill meets three out of four criteria for FDA commissioner voucher International Mounjaro sales exceed estimates by nearly $1 billion Third-quarter beat reinforces Lilly lead in ...